Preventing Ventilator-Associated Pneumonia in Children: An Evidence-Based Protocol
Virginia Bonsal Cooper, RN, MS; Catherine Haut, DNP, CPNP/AC, CCRN
Preventing Ventilator-Associated Pneumonia in Children: An Evidence-Based Protocol: Read Article
Get CE

Learning Objectives

At the completion of this program, you will be able to:
  • Describe pediatric risk factors for ventilator-associated pneumonia (VAP)
  • Identify strategies to prevent pediatric VAP
  • Discuss current evidence in the prevention of VAP in children

Continuing Education Information

CE ID: C133
Total Contact Hours: 1.00
Pharma Hours: 0.0
Synergy Cat: A
Test Expires: 6/1/2017


Ventilator-associated pneumonia, the second most common hospital-acquired infection in pediatric intensive care units, is linked to increased mortality, morbidity, and lengths of stay in the hospital and intensive care unit, adding tremendously to health care costs. Prevention is the most appropriate intervention, but little research has been done in children to identify necessary skills and strategies for prevention. Using a case study approach, this article highlights etiology, risk factors, and available guidelines for the prevention of VAP in the PICU. Evidence, including adult based protocols, Center for Disease Control recommendations, and current research are presented in relation to use in pediatric practice.

Publication/Sponsor Information

Critical Care Nurse is an official publication of the American Association of Critical-Care Nurses (AACN), and copyright belongs to AACN. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopying, recording or by any information storage retrieval system without permission of AACN. For all permission requests, please contact the Copyright Clearance Center, Customer Service, 222 Rosewood Drive, Danvers, MA 01923. (978) 750-8400. The statements and opinions contained herein are solely those of individual contributors and not of the editors, AACN, or The InnoVision Group. The editors, AACN, and The InnoVision Group assume that articles emanating from a particular institution are submitted with the approval of the requisite authority, including all matters pertaining to human studies and patient privacy requirements.

You have currently started taking the test for . To continue your test in progress, select Return to Test. To abandon this test select Cancel.

Your Feedback